{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T05:38:36Z","timestamp":1774417116686,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Soshinkai Nagaokakyo Hospital"},{"DOI":"10.13039\/501100001700","name":"MEXT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Grants-in-Aid for Scientific Research"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.brainres.2017.12.012","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T23:30:17Z","timestamp":1513121417000},"page":"39-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["FKBP12-immunopositive inclusions in patients with \u03b1-synucleinopathies"],"prefix":"10.1016","volume":"1680","author":[{"given":"Yasuyuki","family":"Honjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ayaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Horibe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidefumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brainres.2017.12.012_b0005","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"issue":"4\u20135","key":"10.1016\/j.brainres.2017.12.012_b0010","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0031-9384(02)00934-4","article-title":"Immunophilins and their ligands: insights into survival and growth of human neurons","volume":"77","author":"Avramut","year":"2002","journal-title":"Physiol. Behav."},{"issue":"4","key":"10.1016\/j.brainres.2017.12.012_b0015","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"107","key":"10.1016\/j.brainres.2017.12.012_b0020","first-page":"e53415","article-title":"Sequential extraction of soluble and insoluble alpha-synuclein from Parkinsonian brains","volume":"5","author":"Bandopadhyay","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.brainres.2017.12.012_b0025","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nan.12303","article-title":"Review: the spectrum of clinical features seen with alpha synuclein pathology","volume":"42","author":"Barker","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"30","key":"10.1016\/j.brainres.2017.12.012_b0030","doi-asserted-by":"crossref","first-page":"26687","DOI":"10.1074\/jbc.M110.182303","article-title":"Comparative analysis of different peptidyl-prolyl isomerases reveals FK506-binding protein 12 as the most potent enhancer of alpha-synuclein aggregation","volume":"286","author":"Deleersnijder","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.brainres.2017.12.012_b0035","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1096\/fj.03-1346fje","article-title":"A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson\u2019s disease and related disorders","volume":"18","author":"El-Agnaf","year":"2004","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.brainres.2017.12.012_b9000","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0014-4886(03)00004-9","article-title":"Alpha-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy","volume":"181","author":"Gai","year":"2003","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.brainres.2017.12.012_b0040","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1096\/fj.05-5126fje","article-title":"The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy","volume":"20","author":"Gerard","year":"2006","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.brainres.2017.12.012_b0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1471-4159.2008.05342.x","article-title":"FK506 binding protein 12 differentially accelerates fibril formation of wild type alpha-synuclein and its clinical mutants A30P or A53T","volume":"106","author":"Gerard","year":"2008","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.brainres.2017.12.012_b0050","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1523\/JNEUROSCI.5983-09.2010","article-title":"Inhibition of FK506 binding proteins reduces alpha-synuclein aggregation and Parkinson\u2019s disease-like pathology","volume":"30","author":"Gerard","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2017.12.012_b0060","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/sctm.16-0362","article-title":"Human neural progenitor transplantation rescues behavior and reduces \u03b1-synuclein in a transgenic model of dementia with Lewy bodies","volume":"6","author":"Goldberg","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"1349","key":"10.1016\/j.brainres.2017.12.012_b0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2010.06.016","article-title":"Protein disulfide isomerase-immunopositive inclusions in patients with Alzheimer disease","volume":"19","author":"Honjo","year":"2010","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2017.12.012_b0070","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3233\/JAD-130632","article-title":"Protein disulfide isomerase P5-immunopositive inclusions in patients with Alzheimer\u2019s disease","volume":"38","author":"Honjo","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.brainres.2017.12.012_b0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1440-1789.2003.00530.x","article-title":"Dementia with Lewy bodies: reclassification of pathological subtypes and boundary with Parkinson\u2019s disease or Alzheimer\u2019s disease","volume":"24","author":"Iseki","year":"2004","journal-title":"Neuropathology"},{"issue":"3","key":"10.1016\/j.brainres.2017.12.012_b0080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00401-002-0644-3","article-title":"Dementia with Lewy bodies from the perspective of tauopathy","volume":"105","author":"Iseki","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"10","key":"10.1016\/j.brainres.2017.12.012_b0085","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2174\/1871527315666160920160512","article-title":"An overview on the role of \u03b1 -synuclein in experimental models of Parkinson\u2019s disease from pathogenesis to therapeutics","volume":"15","author":"Javed","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"6","key":"10.1016\/j.brainres.2017.12.012_b0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2017.12.012_b0095","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(00)00210-2","article-title":"Postischemic changes in the immunophilin FKBP12 in the rat brain","volume":"84","author":"Kato","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"4","key":"10.1016\/j.brainres.2017.12.012_b0100","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1523\/JNEUROSCI.15-04-02985.1995","article-title":"Neuronal regeneration enhances the expression of the immunophilin FKBP-12","volume":"15","author":"Lyons","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.12.012_b0105","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-017-2382-x","article-title":"The oligomer hypothesis in \u03b1-synucleinopathy","author":"Ono","year":"2017","journal-title":"Neurochem Res."},{"issue":"Pt 2","key":"10.1016\/j.brainres.2017.12.012_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","article-title":"The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology","volume":"117","author":"Papp","year":"1994","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.brainres.2017.12.012_b0115","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neulet.2009.04.062","article-title":"A peptidyl-prolyl isomerase, FKBP12, accumulates in Alzheimer neurofibrillary tangles","volume":"459","author":"Sugata","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.12.012_b0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for \u03b1-synuclein pathology","volume":"79","author":"Vaikath","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2\u20133","key":"10.1016\/j.brainres.2017.12.012_b0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"9","key":"10.1016\/j.brainres.2017.12.012_b0130","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0168-9525(02)02729-4","article-title":"Mouse and fly models of neurodegeneration","volume":"18","author":"Zoghbi","year":"2002","journal-title":"Trends Genet."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317305462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317305462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T14:00:34Z","timestamp":1655906434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317305462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":26,"alternative-id":["S0006899317305462"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.12.012","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FKBP12-immunopositive inclusions in patients with \u03b1-synucleinopathies","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}